InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Koppel Adam, Director. Officer active across 4 companies, notably Dicerna Pharmaceuticals Inc. Cumulatively, 10 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €139.6m. History available since 3 June 2021. The latest transaction was filed on 20 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Koppel Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
16,875,000 sharesCommon StockSEC:0001193125-26-164407:0
4,145,768 sharesCommon StockSEC:0001193125-26-164407:1
1,562,500 shares@ US$16.00100.0% of flowCommon StockSEC:0001193125-26-164407:2
Canonical exit: 19 Jul 2026 (T+90)
3,282 sharesCommon StockSEC:0000950170-24-090903:0
10,461 sharesCommon StockSEC:0000950170-24-070855:0
904,160 shares@ US$5.53100.0% of flowCommon StockSEC:0000950170-24-004276:0
5,480,052 shares@ US$22.81100.0% of flowCommon StockSEC:0000899243-23-019971:0
Canonical exit: 14 Jan 2024 (T+90)
3,282 sharesCommon StockSEC:0000899243-23-015220:0
3,333 shares@ US$38.25100.0% of flowCommon StockSEC:0000899243-21-050036:0
3,333 shares0Common StockSEC:0000899243-21-022369:0
10 of 10 declarations
About Koppel Adam
Koppel Adam is a Board Member at Dicerna Pharmaceuticals Inc. He plays an important role in the company's leadership, providing his expertise to guide strategic decisions and foster innovation.
